4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0000950170-23-068575
SVP and General Counsel sold 2,800 shares at an average $221.89 ($621,294)
- SVP and General Counsel acquired 2,800 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lynch Brian Joseph SVP and General Counsel | 2023-12-04 | Option exercise | +800 | $73.75 | $59,000 | 15,801 | D |
| Lynch Brian Joseph SVP and General Counsel | 2023-12-04 | Option exercise | +1,000 | $87.09 | $87,090 | 16,801 | D |
| Lynch Brian Joseph SVP and General Counsel | 2023-12-04 | Sale | −800 | $215.73 | $172,584 | 16,001 | D |
| Lynch Brian Joseph SVP and General Counsel | 2023-12-04 | Sale | −1,000 | $221.38 | $221,380 | 15,001 | D |
| Lynch Brian Joseph SVP and General Counsel | 2023-12-05 | Option exercise | +1,000 | $87.09 | $87,090 | 16,001 | D |
| Lynch Brian Joseph SVP and General Counsel | 2023-12-05 | Sale | −1,000 | $227.33 | $227,330 | 15,001 | D |
| Derivatives | |||||||
| Lynch Brian Joseph SVP and General Counsel | 2023-12-04 | Option exercise · Stock Option (Right to Buy) | −800 | 20,200 | D | ||
| Lynch Brian Joseph SVP and General Counsel | 2023-12-04 | Option exercise · Stock Option (Right to Buy) | −1,000 | 44,000 | D | ||
| Lynch Brian Joseph SVP and General Counsel | 2023-12-05 | Option exercise · Stock Option (Right to Buy) | −1,000 | 43,000 | D | ||
| Open-market sales · 2,800 sh · avg $221.89 · $621,294 | |||||||
Loading xslF345X05/ownership.xml…